Gastrectomy for Gastric Cancer in Patients with BMI ≥ 30 kg/m
Obesity is a major health issue in the modern world population and a risk factor for surgical procedures. This study examined perioperative and oncologic results of gastrectomy in obese patients diagnosed with gastric cancer. BMI ≥30 kg/m² was used to designate obesity. Five hundred and one patients...
Gespeichert in:
| Veröffentlicht in: | The American surgeon 2020-02, Vol.86 (2), p.158-163 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 163 |
|---|---|
| container_issue | 2 |
| container_start_page | 158 |
| container_title | The American surgeon |
| container_volume | 86 |
| creator | Sahakyan, Mushegh A Shahbazyan, Sevak S Martirosyan, Aram Gabrielyan, Artak Petrosyan, Hmayak Sahakyan, Artur M |
| description | Obesity is a major health issue in the modern world population and a risk factor for surgical procedures. This study examined perioperative and oncologic results of gastrectomy in obese patients diagnosed with gastric cancer. BMI ≥30 kg/m² was used to designate obesity. Five hundred and one patients were operated throughout the study period (2009-2018). The outcomes in obese patients (n = 205) were compared with those with normal weight (n = 171) and overweight (n = 125). The mean BMI was significantly different between the groups: 21.9
26.7
33.3 kg/m² (
< 0.01), respectively. Obesity was associated with higher incidence of comorbidities, longer operative time, and increased blood loss. Postoperative and short-term oncologic outcomes were similar. Median follow-up was 24 months with similar recurrence rates in the three groups. Median survival was comparable between the normal weight, overweight, and obese patients-36 (27-45)
42 (30-53)
32 (17-47) months, respectively (
= 0.63). Obesity itself does not deteriorate the surgical outcomes of gastrectomy in patients with gastric cancer. Although technically demanding in obese patients, adequate lymph node yield and satisfactory long-term oncologic outcomes can be achieved in this group. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2369422608</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2369422608</sourcerecordid><originalsourceid>FETCH-LOGICAL-p141t-8257470d74c551cf57a2030008e5938a1ffb31c5bb890b2d5be4b673ed8b369b3</originalsourceid><addsrcrecordid>eNo1j0tOwzAYhC0kREvhCshLNhF-_YmzQhBBqdQKFrCObMcBQ17YjlCP0INwMU5CRMtqNNKnTzNHaE4BIMkl4zN0GsI7IUSkQE_QjDNK0pySObpeqhC9NbFvt7juPf7rzuBCdcZ67Dr8pKKzXQz4y8U3fLtZ4Z_dN-YEf7xetWfouFZNsOeHXKCX-7vn4iFZPy5Xxc06GaigMZEMMpGRKhMGgJoaMsUInwZJCzmXita15tSA1jInmlWgrdBpxm0lNU9zzRfocu8dfP852hDL1gVjm0Z1th9DySZKMJYSOaEXB3TUra3KwbtW-W35f5r_AtQFUCs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2369422608</pqid></control><display><type>article</type><title>Gastrectomy for Gastric Cancer in Patients with BMI ≥ 30 kg/m</title><source>SAGE Complete A-Z List</source><source>MEDLINE</source><creator>Sahakyan, Mushegh A ; Shahbazyan, Sevak S ; Martirosyan, Aram ; Gabrielyan, Artak ; Petrosyan, Hmayak ; Sahakyan, Artur M</creator><creatorcontrib>Sahakyan, Mushegh A ; Shahbazyan, Sevak S ; Martirosyan, Aram ; Gabrielyan, Artak ; Petrosyan, Hmayak ; Sahakyan, Artur M</creatorcontrib><description>Obesity is a major health issue in the modern world population and a risk factor for surgical procedures. This study examined perioperative and oncologic results of gastrectomy in obese patients diagnosed with gastric cancer. BMI ≥30 kg/m² was used to designate obesity. Five hundred and one patients were operated throughout the study period (2009-2018). The outcomes in obese patients (n = 205) were compared with those with normal weight (n = 171) and overweight (n = 125). The mean BMI was significantly different between the groups: 21.9
26.7
33.3 kg/m² (
< 0.01), respectively. Obesity was associated with higher incidence of comorbidities, longer operative time, and increased blood loss. Postoperative and short-term oncologic outcomes were similar. Median follow-up was 24 months with similar recurrence rates in the three groups. Median survival was comparable between the normal weight, overweight, and obese patients-36 (27-45)
42 (30-53)
32 (17-47) months, respectively (
= 0.63). Obesity itself does not deteriorate the surgical outcomes of gastrectomy in patients with gastric cancer. Although technically demanding in obese patients, adequate lymph node yield and satisfactory long-term oncologic outcomes can be achieved in this group.</description><identifier>EISSN: 1555-9823</identifier><identifier>PMID: 32106910</identifier><language>eng</language><publisher>United States</publisher><subject>Blood Loss, Surgical - statistics & numerical data ; Body Mass Index ; Comorbidity ; Female ; Gastrectomy - mortality ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Obesity - complications ; Obesity - mortality ; Operative Time ; Overweight - complications ; Stomach Neoplasms - complications ; Stomach Neoplasms - mortality ; Stomach Neoplasms - surgery ; Treatment Outcome</subject><ispartof>The American surgeon, 2020-02, Vol.86 (2), p.158-163</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32106910$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sahakyan, Mushegh A</creatorcontrib><creatorcontrib>Shahbazyan, Sevak S</creatorcontrib><creatorcontrib>Martirosyan, Aram</creatorcontrib><creatorcontrib>Gabrielyan, Artak</creatorcontrib><creatorcontrib>Petrosyan, Hmayak</creatorcontrib><creatorcontrib>Sahakyan, Artur M</creatorcontrib><title>Gastrectomy for Gastric Cancer in Patients with BMI ≥ 30 kg/m</title><title>The American surgeon</title><addtitle>Am Surg</addtitle><description>Obesity is a major health issue in the modern world population and a risk factor for surgical procedures. This study examined perioperative and oncologic results of gastrectomy in obese patients diagnosed with gastric cancer. BMI ≥30 kg/m² was used to designate obesity. Five hundred and one patients were operated throughout the study period (2009-2018). The outcomes in obese patients (n = 205) were compared with those with normal weight (n = 171) and overweight (n = 125). The mean BMI was significantly different between the groups: 21.9
26.7
33.3 kg/m² (
< 0.01), respectively. Obesity was associated with higher incidence of comorbidities, longer operative time, and increased blood loss. Postoperative and short-term oncologic outcomes were similar. Median follow-up was 24 months with similar recurrence rates in the three groups. Median survival was comparable between the normal weight, overweight, and obese patients-36 (27-45)
42 (30-53)
32 (17-47) months, respectively (
= 0.63). Obesity itself does not deteriorate the surgical outcomes of gastrectomy in patients with gastric cancer. Although technically demanding in obese patients, adequate lymph node yield and satisfactory long-term oncologic outcomes can be achieved in this group.</description><subject>Blood Loss, Surgical - statistics & numerical data</subject><subject>Body Mass Index</subject><subject>Comorbidity</subject><subject>Female</subject><subject>Gastrectomy - mortality</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local</subject><subject>Obesity - complications</subject><subject>Obesity - mortality</subject><subject>Operative Time</subject><subject>Overweight - complications</subject><subject>Stomach Neoplasms - complications</subject><subject>Stomach Neoplasms - mortality</subject><subject>Stomach Neoplasms - surgery</subject><subject>Treatment Outcome</subject><issn>1555-9823</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j0tOwzAYhC0kREvhCshLNhF-_YmzQhBBqdQKFrCObMcBQ17YjlCP0INwMU5CRMtqNNKnTzNHaE4BIMkl4zN0GsI7IUSkQE_QjDNK0pySObpeqhC9NbFvt7juPf7rzuBCdcZ67Dr8pKKzXQz4y8U3fLtZ4Z_dN-YEf7xetWfouFZNsOeHXKCX-7vn4iFZPy5Xxc06GaigMZEMMpGRKhMGgJoaMsUInwZJCzmXita15tSA1jInmlWgrdBpxm0lNU9zzRfocu8dfP852hDL1gVjm0Z1th9DySZKMJYSOaEXB3TUra3KwbtW-W35f5r_AtQFUCs</recordid><startdate>20200201</startdate><enddate>20200201</enddate><creator>Sahakyan, Mushegh A</creator><creator>Shahbazyan, Sevak S</creator><creator>Martirosyan, Aram</creator><creator>Gabrielyan, Artak</creator><creator>Petrosyan, Hmayak</creator><creator>Sahakyan, Artur M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20200201</creationdate><title>Gastrectomy for Gastric Cancer in Patients with BMI ≥ 30 kg/m</title><author>Sahakyan, Mushegh A ; Shahbazyan, Sevak S ; Martirosyan, Aram ; Gabrielyan, Artak ; Petrosyan, Hmayak ; Sahakyan, Artur M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p141t-8257470d74c551cf57a2030008e5938a1ffb31c5bb890b2d5be4b673ed8b369b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Blood Loss, Surgical - statistics & numerical data</topic><topic>Body Mass Index</topic><topic>Comorbidity</topic><topic>Female</topic><topic>Gastrectomy - mortality</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local</topic><topic>Obesity - complications</topic><topic>Obesity - mortality</topic><topic>Operative Time</topic><topic>Overweight - complications</topic><topic>Stomach Neoplasms - complications</topic><topic>Stomach Neoplasms - mortality</topic><topic>Stomach Neoplasms - surgery</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sahakyan, Mushegh A</creatorcontrib><creatorcontrib>Shahbazyan, Sevak S</creatorcontrib><creatorcontrib>Martirosyan, Aram</creatorcontrib><creatorcontrib>Gabrielyan, Artak</creatorcontrib><creatorcontrib>Petrosyan, Hmayak</creatorcontrib><creatorcontrib>Sahakyan, Artur M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>The American surgeon</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sahakyan, Mushegh A</au><au>Shahbazyan, Sevak S</au><au>Martirosyan, Aram</au><au>Gabrielyan, Artak</au><au>Petrosyan, Hmayak</au><au>Sahakyan, Artur M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gastrectomy for Gastric Cancer in Patients with BMI ≥ 30 kg/m</atitle><jtitle>The American surgeon</jtitle><addtitle>Am Surg</addtitle><date>2020-02-01</date><risdate>2020</risdate><volume>86</volume><issue>2</issue><spage>158</spage><epage>163</epage><pages>158-163</pages><eissn>1555-9823</eissn><abstract>Obesity is a major health issue in the modern world population and a risk factor for surgical procedures. This study examined perioperative and oncologic results of gastrectomy in obese patients diagnosed with gastric cancer. BMI ≥30 kg/m² was used to designate obesity. Five hundred and one patients were operated throughout the study period (2009-2018). The outcomes in obese patients (n = 205) were compared with those with normal weight (n = 171) and overweight (n = 125). The mean BMI was significantly different between the groups: 21.9
26.7
33.3 kg/m² (
< 0.01), respectively. Obesity was associated with higher incidence of comorbidities, longer operative time, and increased blood loss. Postoperative and short-term oncologic outcomes were similar. Median follow-up was 24 months with similar recurrence rates in the three groups. Median survival was comparable between the normal weight, overweight, and obese patients-36 (27-45)
42 (30-53)
32 (17-47) months, respectively (
= 0.63). Obesity itself does not deteriorate the surgical outcomes of gastrectomy in patients with gastric cancer. Although technically demanding in obese patients, adequate lymph node yield and satisfactory long-term oncologic outcomes can be achieved in this group.</abstract><cop>United States</cop><pmid>32106910</pmid><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 1555-9823 |
| ispartof | The American surgeon, 2020-02, Vol.86 (2), p.158-163 |
| issn | 1555-9823 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2369422608 |
| source | SAGE Complete A-Z List; MEDLINE |
| subjects | Blood Loss, Surgical - statistics & numerical data Body Mass Index Comorbidity Female Gastrectomy - mortality Humans Male Middle Aged Neoplasm Recurrence, Local Obesity - complications Obesity - mortality Operative Time Overweight - complications Stomach Neoplasms - complications Stomach Neoplasms - mortality Stomach Neoplasms - surgery Treatment Outcome |
| title | Gastrectomy for Gastric Cancer in Patients with BMI ≥ 30 kg/m |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T01%3A47%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gastrectomy%20for%20Gastric%20Cancer%20in%20Patients%20with%20BMI%20%E2%89%A5%2030%20kg/m&rft.jtitle=The%20American%20surgeon&rft.au=Sahakyan,%20Mushegh%20A&rft.date=2020-02-01&rft.volume=86&rft.issue=2&rft.spage=158&rft.epage=163&rft.pages=158-163&rft.eissn=1555-9823&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E2369422608%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2369422608&rft_id=info:pmid/32106910&rfr_iscdi=true |